Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma

International Journal of Oncology

Volumn 28, Issue 3, 2006, Pages 781-785

  Yin, Shenmin ^a   Goodrich, David W ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Gene therapy; Pancreatic adenocarcinoma; Retinoblastoma gene

Indexed keywords

CELL CYCLE PROTEIN; N5 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN P53;

ADENOCARCINOMA; ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG SCREENING; FLOW CYTOMETRY; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; METHODOLOGY; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; TRANSFECTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33645218018     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.3.781     Document Type: Article

References (23)

1. Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, Pani P, Santacroce S, Simone S, Bucci R and Farber E: Cell death: apoptosis versus necrosis. Int J Oncol 21: 165-170, 2002.
2. Leist M and Jaattela M: Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2: 589-598, 2001.
3. Reed JC: Apoptosis-based therapies. Nat Rev Drug Discov 1: 111-121, 2002.
4. Favrot M, Coll JL, Louis N and Negoescu A: Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Ther 5: 728-739, 1998.
5. Tseng JF and Mulligan RC: Gene therapy for pancreatic cancer. Surg Oncol Clin N Am 11: 537-569, 2002.
6. Halloran CM, Ghaneh P, Neoptolemos JP and Costello E: Gene therapy for pancreatic cancer - current and prospective strategies. Surg Oncol 9: 181-191, 2000.
7. Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B and Roth JA: Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer. Ann Surg Oncol 5: 681-688, 1998.
8. Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, Lemoine NR and Neoptolemos JP: Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Gene Ther 8: 199-208, 2001.
9. Kimura M, Tagawa M, Takenaga K, Yamaguchi T, Saisho H, Nakagawara A and Sakiyama S: Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene. Anticancer Res 17: 879-883, 1997.
10. Vecil GG and Lang FF: Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses. J Neuro-oncol 65: 237-246, 2003.
11. Zeimet AG and Marth C: Why did p53 gene therapy fail in ovarian cancer? Lancet Oncol 4: 415-422, 2003.
12. Durfee T, Mancini MA, Jones D, Elledge SJ and Lee W-H: The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol 127: 609-622, 1994.
13. Feinstein E, Kimchi A, Wallach D, Boldin M and Varfolomeev E: The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci 20: 342-344, 1995.
14. Evans RL, Poe BS and Goodrich DW: Nuclear localization is required for induction of apoptotic cell death by the Rb-associated p84N5 death domain protein. Oncogene 21: 4691-4695, 2002.
15. Yin S, Bailiang W, Xie K and Goodrich DW: Adenovirus-mediated N5 gene transfer inhibits tumor growth and metastasis of human carcinoma in nude mice. Cancer Gene Ther 9: 665-672, 2002.
16. Strasser K, Masuda S, Mason P, Pfannstiel J, Oppizzi M, Rodriguez-Navarro S, Rondon AG, Aguilera A, Struhl K, Reed R and Hurt E: TREX is a conserved complex coupling transcription with messenger RNA export. Nature 417: 304-308, 2002.
17. Li Y, Wang X, Zhang X and Goodrich DW: Human hHpr1/ p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors. Mol Cell Biol 25: 4023-4033, 2005.
18. Rehwinkel J, Herold A, Gari K, Kocher T, Rode M, Ciccarelli FL, Wilm M and Izaurralde E: Genome-wide analysis of mRNAs regulated by the THO complex in Drosophila melanogaster. Nat Struct Mol Biol 11: 558-566, 2004.
19. Guo S, Hakimi MA, Baillat D, Chen X, Farber MJ, Klein- Szanto AJP, Cooch NS, Godwin AK and Shiekhattar R: Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer Res 65: 3011-3016, 2005.
20. Yin S, Hung MC and Goodrich DW: Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosis. Cancer Gene Ther 7: 985-990, 2000.
21. Doostzadeh-Cizeron J, Yin S and Goodrich DW: Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspase-6 and NF-kappaB activation. J Biol Chem 275: 25336-25341, 2000.
22. 2/M cell cycle checkpoint prior to the onset of apoptosis. J Biol Chem 276: 1127-1132, 2001.
23. Schneider G and Schmid RM: Genetic alterations in pancreatic carcinoma. Mol Cancer 2: 15, 2003.